GlassScriptPhysician profile
Michael Rosenblum
NPI 1700084431
$38,736.89
in general payments reported to CMS, 2019-2025
29 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,241 · 2020: $3,543 · 2021: $7,633 · 2022: $6,611 · 2023: $5,326 · 2024: $2,059 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,250 · Food and Beverage: $5,638 · Consulting Fee: $3,000 · Travel and Lodging: $1,803 · Education: $19.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,250.00 |
| Food and Beverage | $5,637.98 |
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $1,802.81 |
| Education | $19.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16,401.38 | 2019-2025 | |
| Boston Scientific Corporation | $7,581.45 | 2019-2025 | Watchman Access System, Watchman Flx |
| Heartflow, INC. | $5,229.52 | 2019-2025 | Ffrct |
| Abbott Laboratories | $4,389.06 | 2019-2025 | Amplatzer Amulet, Jot Dx, Aveir |
| Medtronic, INC. | $1,569.40 | 2022-2025 | Cobalt Dr Mri Surescan, Micra |
| Amgen INC. | $450.48 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $439.18 | 2019-2025 | |
| Cvrx, INC. | $418.03 | 2021-2025 | Barostim Neo System |
| Siemens Medical Solutions USA, INC. | $355.76 | 2024 | Magnetom Sola |
| Alnylam Pharmaceuticals INC. | $216.79 | 2020-2025 | Onpattro, Amvuttra |
| Astrazeneca Pharmaceuticals LP | $197.63 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $186.77 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $186.41 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $126.84 | 2019-2025 | Lifevest |
| Cardiva Medical, INC. | $117.39 | 2021-2024 | Cardiva Vascade 6/7f Vcs |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $111.31 | 2019-2021 | |
| Ge Healthcare | $109.78 | 2021 | |
| Scpharmaceuticals INC. | $105.35 | 2025 | |
| Edwards Lifesciences Corporation | $88.76 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $73.50 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Baxter Healthcare | $72.02 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Novo Nordisk INC | $60.11 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $51.18 | 2021-2023 | Verquvo |
| Irhythm Technologies, INC. | $42.54 | 2019-2023 | Zio Xt Patch |
| Astellas Pharma US INC | $41.76 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.02 | 2019-2021 | |
| Preventice Services, LLC | $39.74 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.09 | 2019 | |
| Cleerly, INC. | $14.64 | 2023 | Cleerly Labs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rosenblum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.